In 38 patients with brain tumor and 17 controls, the blood levels of polyamines were measured, and studies were made on the relationship between these levels and varieties of tumors. In the group of 21 patients with glioma, these levels were significantly higher than those in the control (p<0.01), and in 14 out of 21 patients (67%) the levels exceeded the upper limit of normal range. In one patient with reticulum cell sarcoma, these levels were remarkably high. In the group of 4 patients with metastatic brain tumor, these levels were significantly higher than those in the control (p<0.05), and in 2 of 4 patients the levels exceeded the upper limit of normal range. The levels were all within normal range in 4 patients with neurinoma, 3 patients with meningioma, 2 patients with pituitary adenoma, 1 patient with pinealoma, and 1 patient with cerebellar hemangioblastoma.
Recently, attention has been paid to the re lationship between cellular proliferation and polyamines such as spermidine and spermine. Polyamines are biosynthetized from methionine and ornithine as precursors, and postulated to act in such manner as to accelerate nucleic acid and protein synthesis and activate cellular pro liferation.") These compounds occur in con siderable quantities in most animal and plant tissues examined, and increased concentrations of polyamines have been reported in rapidly growing tissue such as chicken embryo,' .7.10) and regenerating liver. 3 8.10.11) . Dramatically elevated activities of enzymes, which participate in polyamine biosynthesis, are also found in such rapidly growing neoplastic tissue as hepatoma and sarcoma. 10) Many of the investigators who had compared the levels of polyamines in the body fluid be tween patients with cancer and controls re ported that these levels had been higher in the patients, suggesting that the measurements of polyamines might be applicable to clinical exam ination.2.4.5.6. ' 2,14) The author measured the blood levels of poly amines in patients suffering from brain tumor and studied the relationship between these levels and the varieties of tumor, and also in patients with glioma between these levels and the degree of histological malignancy and of the extension of tumor and the effect of the treatment upon the blood levels. This paper deals with the results of these studies.
Materials and Methods
Blood samples were collected from 38 patients with brain tumor hospitalized in the Depart ment of Neurosurgery, the Brain Research In stitute, Niigata University. These included 21 patients with glioma (including 1 patient with thalamic tumor whose histological diagnosis was not verified), 1 patient with pinealoma, 1 patient with cerebellar hemangioblastoma, 1 patient with reticulum cell sarcoma, 4 patients with neurinoma, 3 patients with meningioma, 2 patients with pituitary adenoma, and 4 patients with metastatic brain tumor. As the control group the blood levels of polyamines were meas ured in 17 healthy adults of 23 to 64 years (11 males and 6 females).
Changes in the polyamine levels in the blood caused by surgical insult were investigated after operation in 2 patients subjected to large cran iotomy; one of these patients suffered menin gioma (with 6800 ml of blood transfusion during operation) and the other suffered cerebral arteriovenous mulformation (with 1000ml of blood transfusion).
An attempt was made to detect polyamines from the cerebrospinal fluid in 9 patients with brain tumor. These patients consisted of 6 pa tients with glioma (4 patients with anaplastic glioma and 2 patients with glioblastoma multi forme), I patient with von Recklinghausen's dis ease (combination of meningioma and neur inoma), 1 patient with teratoblastoma, and 1 patient with craniopharyngioma.
To exclude as much influence of infection as possible, some patients were discarded from the experiment when they were suspected of being involved in infection from clinical symptoms, the result of hematological examination, urinalysis and chest X-ray films.
The isolation and estimation of polyamines were carried out by the method of Otsuji, et al.", using ion exchange column chromatography and cellulose-acetate membrane electrophoresis. This method is described briefly as follows: 5 ml of fresh heparinized blood or 15 to 20 ml of fresh cerebrospinal fluid was deproteinized with TCA, which was eliminated with ether. The samples were then injected onto columns packed with ion exchange resin; 1.0 x 6.0 cm, AG50W-X2 (200-400 mesh, H form); and polyamines were washed out with 20 ml of 6N--HC1. The HCl was evaporated by rotary evaporater, and the residue was redissolved in 200 µl of 0.1N-HC1. 50 pl of this solution was subjected to cellulose acetate membrane electrophoresis at 13 volt/cm for 70 min., and amines were quantified by stain ing with amidoblack 1013.
A histological diagnosis of brain tumor was made with specimens obtained by operation or autopsy.
In 18 patients with glioma, the patients were classified into three groups according to the degree of histological malignancy; a group of astrocytoma, of anaplastic glioma and of glio blastoma multiforme. Also, these patients were divided into two groups according to the degree of tumor extension; a group of one lobe lesion in which the tumor localized almost within one lobe, and a group of multiple lobe lesion in which the tumor extended beyond a single lobe.
The extension of tumor was judged from the picture of angiography and the operative finding in most patients or from autopsy findings in patients who died within 1 to 2 months after the measurement of polyamines. Figure 1 shows the result of the polyamine determination in the blood from 17 controls and from 37 patients with brain tumor, and Table I tabulates these levels expressed with the mean (M ± standard deviation (SD). The upper limit of the normal range (M + 2 SD of the controls) were 2.1 pg/ml for spermidine, 1.6 pg/ml for spermine and 3.3 pg/ml for spermidine plus spermine.
Results
In the group of 21 patients with glioma, the number of patients, whose blood levels exceeded the upper limit of the normal range, were 9 patients (43 %) each for spermidine and for sper mine, 13 patients (62 %) for spermidine plus spermine ( Fig. 1) . High values for polyamines were seen in 14 patients (67 %), in whom at least one of the two compounds or the combination of these exceeded the upper limit of the normal range. The polyamine levels in this group ex pressed with M ± SD were 2.2 + 1.0 pg/ml for spermidine, 1.5 ±0.6 pg/ml for spermine and 3.6 + 1.4 for spermidine plus spermine, and all of the values for these three were significantly higher in the group of glioma than in the control (p <0.01) ( Table 1) . No values for the blood polyamines were higher than the upper limit of the normal range ( Fig. 1 ) in 4 patients with neurinoma, 3 patients with meningioma, and 2 patients with pituitary adenoma. Significant differences in these values were not found between the control group and any of these three groups (Table 1 ).
In the group of 4 patients with metastatic brain tumor, the blood values for polyamines were higher than the upper limit of the normal range ( Fig. 1 ) in 2 patients (50%) and the levels of spermine and of spermidine plus spermine were significantly higher in this group than in the control (p<0.05) ( Table 1) .
The blood values for polyamines were re markably high in a patient with reticulum cell sarcoma, but were all within the normal range in a patient with pinealoma, and one with cerebel lar hemangioblastoma ( Fig. 1) (Table 1 ).
An attempt was made to detect polyamines from the cerebrospinal fluid in 9 patients with brain tumor, but this was in vain. Figure 2 shows the values for blood poly amines in 18 patients with glioma classified on the basis of the degree of histological malig nancy, and Table 2 tabulates these values ex pressed with M ± SD. The number of patients whose blood values exceeded the upper limit of the normal range were as follows : out of 5 patients with astrocytoma, one for spermidine plus spermine ; out of 9 patients with anaplastic glioma, 5 each for spermidine and for spermine, and 8 for spermidine plus spermine ; out of 4 patients with glioblastoma multiforme, 3 each for spermidine, for spermine and for spermidine plus spermine (Fig. 2) . The polyamine levels expressed with M ± SD in these three groups were as follows : in the astrocytoma group, 1.7 ±0.4 ug/ml for spermidine, 1.2±0.3 µg/ml for spermine and 2.8 ± 0.5 ug/ml for spermidine plus spermine : in the anaplastic glioma group, 2.2 ±0.8 yg/ml for spermidine, 1.7+0.6 yg/ml for spermine and 3.9 ± 1.2 yg/ml for spermidine plus spermine : in the glioblastoma multiforme group, 2.9 ± 1.6 µg/ml for spermidine, 1.7 ±0.6 pg/ml for spermine and 4.6 ± 1.6 µg/ml for sper midine plus spermine. The values for blood polyamines were significantly higher in all the patient groups than in the control group, except for the astrocytoma group in which no significant difference in the value for spermine was found between the control (Table 2) . A tendency was seen that the higher the degree of histological malignancy, the higher became the blood levels, but there was no significant difference in these levels between any two groups classified on the basis of the degree of histologi cal malignancy. In these 18 patients with glioma, observation was made on the relationship between the de gree of histological malignancy or the size of tumor and the blood levels of polyamines ( Fig.  3) ( Table 3 ). The number of the patients whose values exceeded the upper limit of the normal range were as follows; none out of 3 patients with astrocytoma localizing within a lobe; out of 2 patients with astrocytoma extending beyond a lobe, one for spermidine plus spermine ; out of 6 patients with anaplastic glioma localizing within a lobe, 3 for spermidine, 2 for spermine and 5 for spermidine plus spermine ; out of 3 patients with anaplastic glioma extending beyond a lobe, 2 for spermidine, 3 each for spermine and for sper midine plus spermine ; out of 4 patients with glioblastoma multiforme all of which extended beyond a lobe, 3 each for spermidine, for sper mine and for spermidine plus spermine (Fig. 3) .
The blood values expressed with M ± SD in these groups were as follows : in the group of astrocytoma localizing within a lobe, 1.6±0.5 µg/ml for spermidine, 1.0 ± 0.3 ug/ml for sper mine and 2.5 ± 0.2 µg/ml for spermidine plus spermine : in the group of astrocytoma extend ing beyond a lobe, 1.8 ± 0.3 yg/ml for sper midine, 1.5 ± 0.1 µg/ml for spermine and 3.3 ± 0.4 yg/ml for spermidine plus spermine : in the group of anaplastic glioma localizing within a lobe, 2.1 ± 0.8 µg/ml for spermidine, 1.5 ± 0.6 µg/ml for spermine and 3.6 ± 1.3 µg/ml for sper midine plus spermine : in the group of anaplastic glioma extending beyond a lobe, 2.4±0.9 µg/ml for spermidine, 2.2 ± 0.4 µg/ml for spermine and 4.6 ± 0.7 µg/ml for spermidine plus spermine : in the group of glioblastoma multiforme, 2.9 ± 1.6 µg/ml for spermidine, 1.7 ±0.6 µg/ml for sper mine and 4.6 ± 1.6 pg/ml for spermidine plus spermine (Table 3) . No significant difference in the values for spermidine, spermine and sper midine plus spermine were seen between the control group and the group of astrocytoma localizing within a lobe, or in the value for spermine between the control group and the group of astrocytoma extending beyond a lobe. However, the blood values were significantly higher in the group of anaplastic glioma and of glioblastoma multiforme, regardless of the tumor size, than in the control group. The larger the size of and the higher the degree of histologi cal malignancy of tumor, the higher became the blood values for polyamines. But no significant differences in these values were found between any two of the groups mentioned above. Four patients with glioma were studied before and after treatment in an effort to ascertain the effects on the blood levels of polyamines, and this study was carried out at the time avoiding the period influenced by operative insult (Table  4 ). Two out of 3 patients treated by surgical removal, irradiation and chemotherapy, had elevated levels of polyamines before treatment, and exhibited decrease to the normal range after the treatment. One of these three treated by the same ways, whose values had not been measured before, had normal levels after treatment. The remaining patient who was subjected to irradi ation and chemotherapy but not to surgical removal, had normal levels of polyamines before treatment, but showed elevated levels im mediately after the end of the treatment. ) the blood levels of polyamines. All the investigators mentioned above reported that the levels of polyamines had been higher in patients with cancer than in the normals. In their reports they listed leukemia , malignant lymphoma, various carcinoma and sarcoma as tumor which had given rise and an increase in polyamine levels in the body fluid. Brain tumor was mentioned in 4 cases of Russell, et al."' and I case of Otsuji, et al.') alone. Both authors" ') pointed out that the patients with brain tumor also had several fold higher levels of polyamines than the controls.
No papers seem to have been published on the estimation of the polyamine levels in the cere brospinal fluid in patients with brain tumor. If it were possible to detect the compounds in the cerebrospinal fluid which were associated with the process of cell proliferation, the measure ment of these compounds would be used more readily than those contained in the blood or urine for the estimation of growth of brain tumor without influence caused by any other organs. So an experiment was carried out on the basis of this assumption. In it, samples of cere brospinal fluid amounting to as much as 15-20 ml each were collected from patients in whom anaplastic glioma, glioblastoma multif orme, or teratoblastoma of the third ventricle seemed to be proliferating actively. An attempt The relationship between the types of tumor and the blood levels of polyamines was studied in patients with brain tumor before treatment. The blood levels of polyamines were high in more than a half of the patients with glioma, and were significantly higher (p<0.01) in these pa tients than in the control. Furthermore, a tend ency was seen among the patients with glioma that the higher the degree of histological malig nancy and the greater the size of tumor in lesions of similar histological changes, the higher became the blood levels of polyamines, although the differences in these levels were not so out standing. It is a histological characteristic of glioma that this kind of tumor grows in an infiltrating manner showing no clear boundary from the normal tissue, and that every part of the lesion of tumor does not always present the same histological finding. Therefore, it is always pointed out that one is apt to make a mistake to discuss the character of the tumor by examin ing only one part of the lesion of tumor. Most of the patients with glioma studied in the present investigation were alive, and in many of them the histological diagnosis and the judgement of tumor size were made on the basis of the findings obtained by surgical operation and angio graphy. Accordingly, it should be borne in mind that the relationship between the histological findings or the size of tumor and the blood levels of polyamines were not so accurately evaluated.
Concerning
Russell, et A."' measured urine polyamine excretion before and after treatment, and they reported that urinary polyamines showed a re markable fall in patients with ovarian, brain or testicular tumor after surgical removal, and that another patient with acute myelocytic leukemia had elevated levels of urinary polyamines before treatment, exhibited a several fold increase dur ing chemotherapy, and showed normal levels during a remission period.
Denton, et al." measured urinary excretion of polyamines in patients with acute myelocytic leukemia, and mentioned that there was a mark ed increase in the excretion of spermine over pretreatment values in a patient during chemo therapy that was effective as judged by a fall in the peripheral count of blast cells, and that another patient who did not respond to chemo therapy showed no such changes in polyamine excretion.
The blood levels of polyamines were esti mated in patients with glioma at regular in tervals during the period of treatment. The values were within the normal range after treat ment in patients treated by surgical removal, irradiation and chemotherapy. In another pa tient with thalamic tumor in whom no surgical removal had been performed on account of the localization and who had been subjected to irradiation and chemotherapy, the blood levels of polyamines were found to be rather high immediately after the end of the treatment. A tendency was observed in the patients studied that the blood levels of polyamines became rather high during the period of similar treat ment and returned to the normal range several days after the end of this period, although there was no mentioning about it in this paper. There fore, it is possible for the last patient with thalamic tumor to show normal blood levels of polyamines some days after the end of the treat ment.
Conclusions
Measurement of the blood levels of poly amines is presumed to be a useful method to estimate the state of proliferation of brain tumor. The results reported in this paper suggest that measurement of polyamines in the blood may lead to diagnosis, judgement of the effectiveness of the treatment and prognostic information in patients with brain tumor too, as in patients with malignant tumor of other organs. To ascer tain these assumption, further studies need to be tried in many patients with brain tumor.
